GlassScriptPhysician profile
Matthew Jay Hallman
NPI 1235586546
$18,848.68
in general payments reported to CMS, 2019-2025
42 companies · $1,893 in 2025
The $1,893 reported for 2025 was more than what 81% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $5,000 · 2021: $1,532 · 2022: $3,564 · 2023: $5,416 · 2024: $1,443 · 2025: $1,893.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,432 · Travel and Lodging: $2,320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,432.24 |
| Travel and Lodging | $2,319.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,784.52 | 2020-2025 | Wavewriter Alpha Prime 16, Intracept |
| Medtronic, INC. | $6,717.83 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Stimwave Technologies Incorporated | $683.79 | 2022 | |
| Abbott Laboratories | $529.88 | 2021-2025 | Eterna, Proclaim |
| Collegium Pharmaceutical, INC. | $447.58 | 2021-2025 | Belbuca, Nucynta, Xtampza |
| Abbvie INC. | $374.38 | 2022-2025 | |
| Vertos Medical, INC. | $292.40 | 2021-2023 | Mild Device Kit |
| Nevro Corp. | $287.32 | 2021-2024 | Senza |
| Globus Medical, INC. | $258.72 | 2025 | Senza, Vyrsa V1 |
| Forte Bio-Pharma LLC | $214.14 | 2021-2025 | Prolate, Nalocet, Tanlor |
| Pfizer INC. | $191.71 | 2023-2025 | |
| Si-Bone, INC. | $187.71 | 2022-2023 | |
| Scilex Pharmaceuticals INC. | $178.94 | 2022-2023 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $166.25 | 2022-2023 | Relistor |
| Lundbeck LLC | $159.18 | 2022-2023 | Vyepti |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Hallman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.